U.S. Markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.87 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.45 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.52
    -0.01 (-0.02%)
     
  • Gold

    1,783.10
    +1.20 (+0.07%)
     
  • Silver

    22.68
    +0.13 (+0.56%)
     
  • EUR/USD

    1.1956
    +0.0043 (+0.3587%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • Vix

    20.84
    -0.41 (-1.93%)
     
  • GBP/USD

    1.3334
    -0.0023 (-0.1707%)
     
  • USD/JPY

    104.0850
    -0.1650 (-0.1583%)
     
  • BTC-USD

    18,236.10
    +468.04 (+2.63%)
     
  • CMC Crypto 200

    333.27
    -4.23 (-1.25%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.41 (+0.40%)
     

Post Holdings, Gilead Sciences fall; Pfizer, Hibbett rise

·1 min read

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday:

Pfizer Inc., up 51 cents to $36.70.

The drug developer is asking U.S. regulators to allow emergency use of its COVID-19 vaccine.

Ross Stores Inc., down $1.21 to $108.99.

The discount retailer's third-quarter earnings and revenue beat Wall Street forecasts.

Williams-Sonoma Inc., up $6.67 to $107.71.

Spending on home-related goods helped the cookware and home furnishings retailer beat analysts' third-quarter forecasts.

FireEye Inc., up 91 cents to $15.15.

The computer security software company is buying Respond Software and said it's getting a $400 million investment.

Hibbett Sports Inc., up 51 cents to $42.64.

The sporting goods retailer reported strong online sales and handily beat analysts' third-quarter profit forecasts.

Post Holdings Inc., down $6.17 to $90.53.

The maker of Alpha-Bits and Grape-Nuts cereal disappointed investors with its fourth-quarter financial report.

Gilead Sciences Inc., down 52 cents to $60.11.

The World Health Organization recommended against using the biotechnology company's remdesivir for hospitalized COVID-19 patients.

UnitedHealth Group Inc., down $2.30 to $334.70.

The Trump Administration is planning to release new rules that would lower prescription drug costs, according to media reports.